|
| |
Insider - Substantial Shareholder Hints :
  prescott2006 cash a lot but those old folks haven't figure out a way to boost their business. 30/05/2017 10:29 PM lime1015 Hi, I didn't realize that SCC has undergone share split and bonus issue, and it's not reflected in the latest QR, so the calculation of net current asset value is incorrect. I have removed my comment to avoid misleading others. 11/11/2017 11:19 PM ScrewDriver this is a good company, albeit a bit boring, good as a dividend stock 15/01/2018 6:45 PM Erentitan this stock is a dividend stock. If you hope for capital gain you will be disappointed because a majority of the company's earnings are distributed to s/h in form of dividends hence less money for reinvestment. This reinvestment money is essential to fund future growth. Plus the market cap is merely RM76 million, ultra low market cap will not attract institutional funds which are essential to push up the price further. PE of 12.6 is almost reaching the average small market cap index PE. this stock is purely dividen play giving out about 5-6% yield per annum. Anyway this is newbie brief analysis, I dont dig deeper into the company fundamentals so others might have much better insights than I am. 17/01/2018 2:29 PM thiagarajan81 this counter still alive? good qr but still no body want it.. so bad.. 01/03/2018 12:16 PM WhiteHand This is a stable dividend stock. If u r buying at this current price,0.5. You are able to gain more than 6.5% on dividend Yield, which is much more better than a FD. Assuming the dividend maintained and increases every semi-annual. 10/08/2018 5:30 PM  YAPSS Day 59 of Fundamental Daily, YAPSS will be covering SCC Holdings Berhad's fundamental via a short animated video. I hope it helps and please enjoy the video, see ya! #YAPSS #FundamentalDaily #SCCHoldingsBerhad Click the on the link to find out more: https://youtu.be/rJq51PiFmT0 01/05/2019 10:54 PM YAPSS YAPSS Quick Summary and Free 10 Years Financial Data of SCC Holdings Berhad: https://www.yapss.com/forum/klse-forum/scc-holdings-berhad-scc-0158 13/12/2019 7:37 PM NPRA1985 United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19 TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial. The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine. The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided. The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.” The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization. https://www.forbes.com/sites/roberthart/2020/12/09/united-arab-emirates-claims-chinas-sinopharm-vaccine-is-100-effective-at-preventing-moderate-and-severe-covid-19/?sh=2a60fb42595ca 10/12/2020 12:16 AM DCang Akino This counter has very little ticket : 141 million only. Very easy to goreng if they want to. 01/04/2021 6:10 PM DCang Akino Average target price : RM 2.69. ; Ticket: 141 million only ; Annual financial reports never lose since 2011 ; Why the present market price so low ? 05/04/2021 7:23 AM DCang Akino It started to fry. Hopefully keeps frying this coming Monday. Non-stop frying ! 25/07/2021 5:10 PM  | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
